VidaVinci, Inc.
Alexey Ishchenko is a highly experienced computational chemist currently serving as Principal Scientist at VidaVinci, Inc. since July 2025. Previously, Alexey held the position of Principal Research Investigator at Arvinas from December 2023 to June 2025, where contributions included the modeling of active PROTAC molecules for protein degradation programs. With a robust background at Arvinas as a Senior Research Investigator from 2016 to 2022, Alexey focused on computational modeling of PROTAC-mediated complexes. Earlier roles include Computational Chemistry Consultant at Blueprint Medicines, Senior Staff Scientist at ARIAD Pharmaceuticals, Research Investigator at OSI Pharmaceuticals, and Scientist II at Biogen Idec. Alexey's notable achievements include co-inventing VTP-27999 at Vitae Pharmaceuticals. Educational credentials include a PhD from Harvard University, a Post Masters Certificate from The Johns Hopkins University, and a Master of Arts from Kharkiv State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
VidaVinci, Inc.
VidaVinci, Inc is a venture-backed, privately held biotech company on a mission to pioneer "a new modality to end all modalities". Our goal is to revolutionize drug discovery at scale, address the toughest challenges of existing modalities, and unlock high-impact therapies for patients. Backed by top tier investors, the Company is co-founded by Drs. Gregory Verdine and Hal Barron--renowned industry leaders known for taking on the most daring scientific challenges. Built on a bold vision to redefine therapeutic innovation, we are pushing the boundaries of what’s possible in medicine. Join us to shape the future of drug discovery.